Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer.
Journal: Thyroid : official journal of the American Thyroid Association
Published: June 16, 2020
Phase II Study of Everolimus in Metastatic Malignant Melanoma (NCCTG-N0377, Alliance).
Journal: The oncologist
Published: December 01, 2017
Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell carcinoma previously treated with tyrosine kinase inhibitors: a phase 2 consortium study.
Journal: Cancer chemotherapy and pharmacology
Published: June 18, 2014
Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors.
Journal: World journal of gastroenterology
Published: March 26, 2014
A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H.
Journal: The Journal of clinical endocrinology and metabolism
Published: March 11, 2014
Chemotherapy, Irradiation, and Surgery for Function-preserving Curative Therapy of Primary Extremity Soft Tissue Sarcomas: Initial Treatment With I-MAP and Inhalation GM-CSF During Preoperative Irradiation and Postoperatively.
Journal: American journal of clinical oncology
Published: February 04, 2014
Phase II study of temozolomide (TMZ) and everolimus (RAD001) therapy for metastatic melanoma: a North Central Cancer Treatment Group study, N0675.
Journal: American journal of clinical oncology
Published: January 30, 2013
Systemic treatment in unresectable metastatic well-differentiated carcinoid tumors: consensus results from a modified delphi process.
Journal: Pancreas
Published: December 06, 2012
Phase II trial of intravenous administration of Reolysin(®) (Reovirus Serotype-3-dearing Strain) in patients with metastatic melanoma.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 09, 2012
A multiinstitutional phase 2 trial of pazopanib monotherapy in advanced anaplastic thyroid cancer.
Journal: The Journal of clinical endocrinology and metabolism
Published: July 10, 2012
A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261.
Journal: Gynecologic oncology
Published: February 23, 2012
Development of a multidisciplinary, multicampus subspecialty practice in endocrine cancers.
Journal: Journal of oncology practice
Published: January 05, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026